Org.SUPPLEMENTARY MATERIALSupplementary Material is available at HMG on-line.Human Molecular Genetics, 2013, Vol. 22, No.ACKNOWLEDGEMENTSDetailed acknowledgements by study can be discovered within the supplementary note. Conflict of Interest statement. None declared.FUNDINGThis work was supported by the Academy of Finland (grant numbers 120315, 134839, 129297, 218029, 209072, 129255, 126925, 121584, 124282, 129378, 117787, 41071, 100499, 205585, 118555, 104781, 120315, 129418, 141054); Academy of Finland Center of Excellence in Complex Disease Genetics (grant numbers 213506, 129680); Australian National Health and Health-related Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498); Australian Study Council (grant numbers A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921); British Heart Foundation; Canadian Institutes of Wellness Research (grant number MOP-82893); Conselleria de Sanitat Generalitat Valenciana, and Fundacion Roger Torne; Dutch Asthma Fonds; Emil Aal??tonen Foundation; Erasmus Health-related Center, Rotterdam, the Erasmus University Rotterdam and also the Netherlands Organization for Overall health Investigation and Improvement (grant number 21000074); European Commission (ENGAGE project and grant agreement HEALTH-F4-2007-201413; EURO-BLCS, Framework 5 award QLG1-CT-2000-01643); European Study Council (grant number ERC-230374); Finnish Cultural Foundation; Finnish Foundation of Cardiovascular Investigation; Fundacio La Marato de TV3, Generalitat de Catalunya ??(grant number CIRIT 1999SGR 00241); Genomics of Developmental Trajectories in Twins (grant quantity 1RC2MH089 995-01); German Bundesministerium fuer Forschung und Technology (grant numbers 01 AK 803 A-H, 01 IG 07015 G); Infants Investigation Foundation; Institute Development Award from the Children’s Hospital of Philadelphia; Instituto de Salud Carlos III (grant numbers CB06/02/0041, G03/176, FIS PI041436, PI081151, PI041705, PS09/00432, FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/ 1213, 07/0314, 09/02647); Juho Vainio Foundation; LudwigMaximilians-University’s innovative research priority project MC-Health; Medical Study Council (grant numbers G0601653, G0000934, G0500539, G0600705, G0601653); National Institutes of Wellness (grant numbers R01 HD056465, 5R01MH63706:02); National Institute for Alcohol Abuse and Alcoholism (grant numbers AA-12502, AA-09203, AA-08315); NIH Heart, Lung and Blood Institute (grant number 5R01HL087679-02) by way of the STAMPEED program (grant quantity 1RL1MH083268-01); National Health and Medical Study Council of Australia (grant numbers 403981, 003209); Netherlands Organization for Scientific investigation (grant number NWO/SPI 56-464-14192); Spanish Ministry of Science and Innovation (grant quantity SAF2008-00357); Stichting Astmabestrijding and Ministry on the Atmosphere; Social Insurance coverage Institution of Finland; Telethon Institute for Child Well being Analysis and Females; Twin-family database for behavior genetics and genomics research (grant quantity NWO 480-04-004); Variety 1 DiabetesGenetics Consortium (grant number U01 DK062418); Paavo Nurmi Foundation; Raine Healthcare Investigation Foundation; Research Development Award from the Cotswold Foundation; UK Health-related Study Council (grant number 74882); University of Bristol; University of Western Australia; University Hospital Oulu; University of Oulu (grant quantity 75617); UWA Faculty of Medicine, Dentistry and Well being Sciences; Wellcome Trust (grant numbers 0764.3-(4-Bromophenyl)oxetan-3-ol Chemical name 952729-67-8 Order PMID:23903683